Hexamethylene bisacetamide in myelodysplastic syndrome and acute myelogenous leukemia: a phase II clinical trial with a differentiation-inducing agent (Q33355508)
scientific article published on November 15, 1992
Language:
(P31) (Q13442814)
(P304) 2604-2609
(P407) (Q1860)
(P433) 10
(P478) 80
(P577) Sunday, November 1, 1992
Sunday, November 15, 1992
(P921) (Q42824440)
(Q29496)
(Q954625)
(P953) http://www.bloodjournal.org/cgi/content/abstract/80/10/2604
(P1433) (Q885070)
(P1476) "Hexamethylene bisacetamide in myelodysplastic syndrome and acute myelogenous leukemia: a phase II clinical trial with a differentiation-inducing agent" (language: en)
(P2093) M. Andreeff
R. Stone
J. Michaeli
C. W. Young
W. P. Tong
H. Sogoloff
T. Ervin
D. Kufe
R. A. Rifkind
P. A. Marks
other details
description scientific article published on November 15, 1992

External Links